203 related articles for article (PubMed ID: 27834383)
1. Mapping synaptic glutamate transporter dysfunction in vivo to regions surrounding Aβ plaques by iGluSnFR two-photon imaging.
Hefendehl JK; LeDue J; Ko RW; Mahler J; Murphy TH; MacVicar BA
Nat Commun; 2016 Nov; 7():13441. PubMed ID: 27834383
[TBL] [Abstract][Full Text] [Related]
2. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
Baik SH; Kang S; Son SM; Mook-Jung I
Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
[TBL] [Abstract][Full Text] [Related]
3. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
[TBL] [Abstract][Full Text] [Related]
4. Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease.
Zumkehr J; Rodriguez-Ortiz CJ; Cheng D; Kieu Z; Wai T; Hawkins C; Kilian J; Lim SL; Medeiros R; Kitazawa M
Neurobiol Aging; 2015 Jul; 36(7):2260-2271. PubMed ID: 25964214
[TBL] [Abstract][Full Text] [Related]
5. Region- and age-specific changes in glutamate transport in the AβPP23 mouse model for Alzheimer's disease.
Schallier A; Smolders I; Van Dam D; Loyens E; De Deyn PP; Michotte A; Michotte Y; Massie A
J Alzheimers Dis; 2011; 24(2):287-300. PubMed ID: 21297271
[TBL] [Abstract][Full Text] [Related]
6. Plaque-bearing mice with reduced levels of oligomeric amyloid-beta assemblies have intact memory function.
Lesné S; Kotilinek L; Ashe KH
Neuroscience; 2008 Feb; 151(3):745-9. PubMed ID: 18155846
[TBL] [Abstract][Full Text] [Related]
7. Microglia limit the expansion of β-amyloid plaques in a mouse model of Alzheimer's disease.
Zhao R; Hu W; Tsai J; Li W; Gan WB
Mol Neurodegener; 2017 Jun; 12(1):47. PubMed ID: 28606182
[TBL] [Abstract][Full Text] [Related]
8. Amyloid Plaques Show Binding Capacity of Exogenous Injected Amyloid-β.
Gureviciene I; Gurevicius K; Mugantseva E; Kislin M; Khiroug L; Tanila H
J Alzheimers Dis; 2017; 55(1):147-157. PubMed ID: 27636846
[TBL] [Abstract][Full Text] [Related]
9. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
10. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
11. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
Bi Oh S; Suh N; Kim I; Lee JY
Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
[TBL] [Abstract][Full Text] [Related]
12. Learning impairment by minimal cortical injury in a mouse model of Alzheimer's disease.
Zou J; Wang M; Uchiumi O; Shui Y; Ishigaki Y; Liu X; Tajima N; Akai T; Iizuka H; Kato N
Brain Res; 2016 Apr; 1637():56-63. PubMed ID: 26876740
[TBL] [Abstract][Full Text] [Related]
13. Nardilysin prevents amyloid plaque formation by enhancing α-secretase activity in an Alzheimer's disease mouse model.
Ohno M; Hiraoka Y; Lichtenthaler SF; Nishi K; Saijo S; Matsuoka T; Tomimoto H; Araki W; Takahashi R; Kita T; Kimura T; Nishi E
Neurobiol Aging; 2014 Jan; 35(1):213-22. PubMed ID: 23954170
[TBL] [Abstract][Full Text] [Related]
14. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
[TBL] [Abstract][Full Text] [Related]
15. Iron, Copper, and Zinc Concentration in Aβ Plaques in the APP/PS1 Mouse Model of Alzheimer's Disease Correlates with Metal Levels in the Surrounding Neuropil.
James SA; Churches QI; de Jonge MD; Birchall IE; Streltsov V; McColl G; Adlard PA; Hare DJ
ACS Chem Neurosci; 2017 Mar; 8(3):629-637. PubMed ID: 27958708
[TBL] [Abstract][Full Text] [Related]
16. Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP mice.
Kung MP; Hou C; Zhuang ZP; Cross AJ; Maier DL; Kung HF
Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1136-45. PubMed ID: 15007564
[TBL] [Abstract][Full Text] [Related]
17. Mutant ubiquitin decreases amyloid β plaque formation in a transgenic mouse model of Alzheimer's disease.
van Tijn P; Dennissen FJ; Gentier RJ; Hobo B; Hermes D; Steinbusch HW; Van Leeuwen FW; Fischer DF
Neurochem Int; 2012 Oct; 61(5):739-48. PubMed ID: 22797007
[TBL] [Abstract][Full Text] [Related]
18. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of amyloid-β plaque formation by α-synuclein.
Bachhuber T; Katzmarski N; McCarter JF; Loreth D; Tahirovic S; Kamp F; Abou-Ajram C; Nuscher B; Serrano-Pozo A; Müller A; Prinz M; Steiner H; Hyman BT; Haass C; Meyer-Luehmann M
Nat Med; 2015 Jul; 21(7):802-7. PubMed ID: 26099047
[TBL] [Abstract][Full Text] [Related]
20. Acceleration of amyloidogenesis and memory impairment by estrogen deficiency through NF-κB dependent beta-secretase activation in presenilin 2 mutant mice.
Hwang CJ; Park MH; Choi MK; Choi JS; Oh KW; Hwang DY; Han SB; Hong JT
Brain Behav Immun; 2016 Mar; 53():113-122. PubMed ID: 26593275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]